Latest Leadership Change News

dorsaVi Limited has acquired a cutting-edge neuromorphic processing-in-memory technology portfolio, positioning itself at the forefront of next-generation wearable and robotics intelligence. This strategic move, coupled with leadership changes, signals a new era for the company’s adaptive biosensor and robotics platforms.

Pro-Pac Packaging has entered voluntary administration, leading to the redundancy of its CEO and an extended timeline for creditor meetings in Australia and New Zealand.

Monash IVF Group has appointed Dr Victoria Atkinson as its new Managing Director and CEO, effective May 2026, signaling a strategic leadership shift for the assisted reproductive services provider.

Life360, Inc. reported robust Q3 2025 financial results driven by subscription and partnership revenue growth, alongside a leadership transition and strategic capital moves. The company also announced a major acquisition to bolster its advertising platform.

Tolu Minerals has appointed Dr Chris Muller as Managing Director and CEO, signaling a strategic push towards ramped-up exploration and resource development in Papua New Guinea.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

Integral Diagnostics has appointed Jason Martinez as its new CEO, set to lead the company’s growth and innovation efforts starting in 2026. Martinez brings over two decades of diagnostic imaging leadership experience, promising a strategic focus on expansion and operational excellence.

Nine Entertainment reported a resilient FY25 with strategic transformation gains, digital subscription growth, and a major capital return following the sale of its Domain stake. Leadership changes and regulatory challenges frame its path forward.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

The Calmer Co. International Limited announces a leadership change with James S. Tonkin appointed Chairman as the company accelerates its U.S. market growth in natural kava products.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.